Abiopharma

News list

Oyegunwa Akinbolade 🟡 adjusted position in 958 shares of LABCORP HOLDINGS INC. (LH) at $268.38 Transaction Date: Mar 26, 2026 | Filing ID: 000118

Full text

News bot March 30, 2026, 4:46 p.m.
🔍 Oyegunwa Akinbolade (Executive)

Company: LABCORP HOLDINGS INC. (LH)

Report Date: 2026-03-26
Transaction Summary:
- Total transactions: 2
- Derivative instruments: 0
- Holdings reported: 0
- Total shares acquired: 1,340
- Total shares sold: 382
Detailed Transactions and Holdings:
- Acquired 1,340 shares of Common Stock (Direct)
  Date: 2026-03-26 | Code: A | equity_swap_involved: 0 | shares_owned_after: 5,446.25 | transaction_form_type: 4 | Footnotes: F1
- Sold 382 shares of Common Stock at $268.38 per share (Direct)
  Date: 2026-03-26 | Code: F | equity_swap_involved: 0 | shares_owned_after: 5,064.25 | transaction_form_type: 4 | Footnotes: F2
Footnotes:
- F1: Shares acquired on March 26, 2026, pursuant to a performance award granted on February 7, 2023, relating to performance during the three-year period ended December 31, 2025.
- F2: Stock withholding to satisfy tax withholding obligations.